Lyophilized Sterile Vial
Tested: 99.5% (BPC) / 99.3% (TB-500)
Current Lot: MV-2026-WLV10-04
Multi-Peptide Precision Synergy
Wolverine Precision Blend (BPC-157 + TB-500)
10mg / 5mL Lyophilized Multi-Compound • HPLC Purity: 99.5% (BPC) / 99.3% (TB-500) • Target: ≥ 99.0% per component
Synergistic dual-peptide formulation pairing BPC-157 angiogenic pentadecapeptide with TB-500 (Thymosin Beta-4 active fragment) for advanced tissue recovery and actin regulation models.
Wholesale Commercial Pricing
Verified Provider Portal Required
• No consumer checkout • Tiered volume schedules • Certificate included with shipment
Formula Multi-Component Lyophilized Matrix
Molecular Weight Co-Lyophilized Dual Active
CAS Registry # 137525-51-0 / 77591-33-4
Peptide Sequence / Structure BPC-157 (5mg) + Thymosin Beta-4 Ac-LKKTETQ (5mg)
Current Lot Verification
Historical Lot Archive → Lot #MV-2026-WLV10-04 Analytical Results
Independent laboratory testing panel for active distribution batch.
| Analysis Category | Reported Result | Analytical Method | Verification Status |
|---|---|---|---|
| Component 1 Purity (BPC-157) | 99.5% | RP-HPLC Dual Gradient | Conforms |
| Component 2 Purity (TB-500) | 99.3% | RP-HPLC Dual Gradient | Conforms |
| Quantitative Content Ratio | 5.02mg : 5.04mg | LC-MS/MS Quantification | Conforms |
| Bacterial Endotoxin | < 0.05 EU/mg | USP <85> | Conforms |
Biological Mechanism of Action
Combines focal adhesion kinase signaling and VEGFR2 upregulation (BPC-157) with G-actin sequestration and cell migration enhancement (TB-500).
Research Focus Areas: Dual Synergistic Action Actin Sequestration Tissue Regeneration
Scientific Literature Cross-Reference
Explore primary peer-reviewed papers, PubMed indexes, and pharmacology data for Wolverine Blend.